Kamada (KMDA) Operating Expenses (2012 - 2026)
Kamada's (KMDA) quarterly Operating Expenses came in at $7.4 million in Q1 2026, down 12.25% YoY from $8.4 million in Q1 2025, and down 13.17% on a QoQ basis from $8.5 million in Q4 2025.
Kamada (KMDA) Operating Expenses (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Operating Expenses data on file, last reported at $7.4 million in Q1 2026.
- Quarterly Operating Expenses fell 12.25% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.4 million (changed 0.49% YoY) and the FY2025 annual result came in at $31.7 million, up 0.73% from the prior year.
- Operating Expenses declined to $7.4 million in Q1 2026, from $8.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $8.5 million in Q4 2025 to a low of $6283.0 in Q3 2022.
- A 5-year average of $5.6 million and a median of $7.4 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses plunged 99.91% — and 2024, when it surged 121437.07%.
- Tracing KMDA's Operating Expenses over 5 years: stood at $6.3 million in 2022, then grew by 11.14% to $7.0 million in 2023, then grew by 5.29% to $7.4 million in 2024, then increased by 15.53% to $8.5 million in 2025, then slipped by 13.17% to $7.4 million in 2026.
- The last three Operating Expenses figures came in at $7.4 million (Q1 2026), $8.5 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Kamada | 458.29 Mn | 428.82 Mn | 22.47 Mn | 8.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.02 Mn |
| Mar 31, 2026 | 7.41 Mn |
| Dec 31, 2025 | 8.53 Mn |
| Sep 30, 2025 | 7.44 Mn |
| Jun 30, 2025 | 7,286.00 |
| Mar 31, 2025 | 8.44 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Sep 30, 2024 | 7.44 Mn |
| Jun 30, 2024 | 8,581.00 |
| Mar 31, 2024 | 8.08 Mn |
| Dec 31, 2023 | 7.02 Mn |
| Sep 30, 2023 | 6.72 Mn |
| Jun 30, 2023 | 7.77 Mn |
| Mar 31, 2023 | 6,649.00 |
| Dec 31, 2022 | 6.31 Mn |
| Sep 30, 2022 | 6,283.00 |
| Jun 30, 2022 | 5.95 Mn |
| Mar 31, 2022 | 7.43 Mn |
| Dec 31, 2021 | 7.28 Mn |
| Sep 30, 2021 | 5.24 Mn |